nach oben

Journal of General Internal Medicine

Erschienen in:

01.07.2015 | Capsule Commentary

Capsule Commentary on Hoffman et al., Self-Reported Health Status Predicts Other-Cause Mortality in Men with Localized Prostate Cancer: Results from the Prostate Cancer Outcomes Study

verfasst von: Eva H DuGoff, PhD MPP

Erschienen in: Journal of General Internal Medicine | Ausgabe 7/2015

Einloggen, um Zugang zu erhalten

Excerpt

Routine screenings for prostate, breast, and colorectal cancers are generally not recommended for individual with limited life expectancy.1 Despite the consensus from specialty societies and clinical practice guidelines, these tests are commonly performed in individuals with high risk of mortality within 5 years.2 The frequency with which these tests are overused speaks to the challenge of estimating life expectancy in clinical practice. To address this challenge, Hoffman and colleagues3 offer an important contribution to the growing literature on how to best target clinical services based on life expectancy estimates.4,5 …

Boodman SG. Concern is growing that the elderly get too many medical tests, in Kaiser Health News. Washington, DC; 2011.

Royce TJ, et al. Cancer screening rates in individuals with different life expectancies. JAMA Intern Med. 2014;174(10):1558–1565.PubMedCrossRef

Hoffman RM, et al. Self-reported health status predicts other-cause mortality in men with localized prostate cancer: results from the prostate cancer outcomes study. J Gen Intern Med. 2015; doi:10.1007/s11606-014-3171-8.

Cho H, et al. Comorbidity-adjusted life expectancy: a new tool to inform recommendations for optimal screening strategies. Ann Intern Med. 2013;159(10):667–676.PubMedCrossRef

Lee SJ, et al. Individualizing life expectancy estimates for older adults using the Gompertz Law of Human Mortality. PLoS One. 2014;9(9):e108540.PubMedCentralPubMedCrossRef

Titel: Capsule Commentary on Hoffman et al., Self-Reported Health Status Predicts Other-Cause Mortality in Men with Localized Prostate Cancer: Results from the Prostate Cancer Outcomes Study
verfasst von: Eva H DuGoff, PhD MPP
Publikationsdatum: 01.07.2015
Verlag: Springer US
Erschienen in: Journal of General Internal Medicine / Ausgabe 7/2015
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI: https://doi.org/10.1007/s11606-015-3188-7

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

19.04.2024 | Vorhofflimmern | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Capsule Commentary on Hoffman et al., Self-Reported Health Status Predicts Other-Cause Mortality in Men with Localized Prostate Cancer: Results from the Prostate Cancer Outcomes Study

Excerpt

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2015

The Patient-Centered Medical Home: Preparation of the Workforce, More Questions than Answers

Building a Career as a Delivery Science Researcher in a Changing Health Care Landscape

The First Step is the Hardest: Overcoming Barriers to Primary Care

A Problematic Palsy: An Exercise in Clinical Reasoning

Tell Me Your Story: A Pilot Narrative Medicine Curriculum During the Medicine Clerkship

Medical Students’ Views and Knowledge of the Affordable Care Act: A Survey of Eight U.S. Medical Schools

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Update Innere Medizin